Advertisement
Screener

GeneDx Holdings Corp. (WGS) Purchase Obligation, to be Paid, Year One

GeneDx Holdings Corp. Purchase Obligation, to be Paid, Year One

GeneDx Holdings Corp. (WGS) had Purchase Obligation, to be Paid, Year One of $2.64 million as of 2023-12-31, per its 10-K filed 2024-02-23.

Discontinued › Notes › Commitment and Contingencies › Purchase Obligation, Fiscal Year Maturity

us-gaap:PurchaseObligationDueInNextTwelveMonths · last filed 2024-02-23

  • 2023-12-31: Purchase Obligation, to be Paid, Year One $2.64M.
  • 2022-12-31: Purchase Obligation, to be Paid, Year One $5.74M.
  • 2021-12-31: Purchase Obligation, to be Paid, Year One $16.65M.
Period endPurchase Obligation, to be Paid, Year One
2023-12-31$2.64M
10-K · filed 2024-02-23
2022-12-31$5.74M
10-K · filed 2023-03-16
2021-12-31$16.65M
10-K · filed 2022-03-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Privia Health Group, Inc. (PRVA)United States$2.477B115.52
Pennant Group, Inc. (PNTG)United States$1.386B39.84
U S PHYSICAL THERAPY INC /NV (USPH)United States$1.251B32.48
Omada Health, Inc. (OMDA)United States$1.207B309.08
InnovAge Holding Corp. (INNV)United States$1.206B-635.60
LifeStance Health Group, Inc. (LFST)United States$4.510B80.86
Strata Critical Medical, Inc. (SRTA)United States$0.467B11.33
DocGo Inc. (DCGO)United States$0.034B-0.25
VSEE HEALTH, INC. (VSEE)United States$0.003B
Agape ATP Corp (ATPC)$0.002B